X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
0
USA (Orange Book)
Europe
0
Canada
Australia
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
https://www.fiercepharma.com/pharma/3-big-pharma-companies-33-phase-3-trials-race-supremacy-adc-field
https://www.prnewswire.com/news-releases/ideaya-biosciences-announces-first-patient-in-for-phase-1-clinical-trial-evaluating-ide397-and-trodelvy-combination-in-mtap-deletion-bladder-cancer-302181366.html
https://www.reuters.com/business/healthcare-pharmaceuticals/gsk-blood-cancer-drug-nearly-halves-risk-death-late-stage-trial-2024-06-02/
https://endpts.com/asco24-merck-kelun-trumpet-phase-3-breast-cancer-data-for-anti-trop2-adc/
https://www.fiercepharma.com/pharma/gilead-writes-24b-trodelvy-ceo-underscores-time-focused-execution
https://www.fiercepharma.com/pharma/teva-snares-150m-abingworth-funding-propel-late-stage-asthma-rescue-inhaler
https://www.prnewswire.com/news-releases/dragonfly-announces-clinical-collaboration-exploring-combinations-of-dragonflys-df1001-her-2-trinket-with-gileads-trodelvy-in-two-cancer-indications-302062613.html
https://www.reuters.com/business/healthcare-pharmaceuticals/gilead-says-trodelvy-fails-meet-primary-goal-2nd-line-lung-cancer-trial-2024-01-22/
https://www.gilead.com/news-and-press/press-room/press-releases/2023/11/gileads-leadership-in-metastatic-breast-cancer-showcased-with-new-trodelvy-data-at-san-antonio-breast-cancer-symposium-2023
https://www.onclive.com/view/sacituzumab-govitecan-plus-enfortumab-vedotin-shows-early-promise-in-metastatic-urothelial-carcinoma
https://www.gilead.com/news-and-press/press-room/press-releases/2023/6/gilead-receives-chmp-positive-opinion-for-trodelvy-in-pretreated-hrher2-metastatic-breast-cancer
https://www.onclive.com/view/sacituzumab-govitecan-approaches-eu-approval-for-pretreated-hr-metastatic-breast-cancer
https://www.fiercebiotech.com/biotech/gilead-picks-small-parp1-biotech-find-mate-trodelvy-and-take-lynparza
https://www.forbes.com/sites/joshuacohen/2023/05/01/dutch-ministry-of-health-will-not-reimburse-gileads-breast-cancer-drug-trodelvy/?sh=18cb6ee753b0
https://www.fiercepharma.com/pharma/gilead-confident-cancer-sales-car-t-manufacturing-capabilities
https://www.fiercebiotech.com/biotech/astrazeneca-gilead-get-new-challenger-pyramid-deviates-trk-bag-antibody-drug-conjugate
https://www.prnewswire.com/news-releases/everest-medicines-receives-full-upfront-payment-from-gilead-for-trodelvy-related-transaction-boosting-pro-forma-cash-reserves-301781641.html
https://www.nasdaq.com/articles/gilead-:-phase-2-data-show-benefit-of-trodelvy-across-multiple-types-of-metastatic
https://www.fiercepharma.com/marketing/patients-paintings-vmlyr-gilead-use-ai-create-canvases-breast-cancer-testimonies
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-expanded-use-gileads-breast-cancer-drug-2023-02-03/
https://www.clinicaltrialsarena.com/news/gilead-sciences-trodelvy-strata-path/
https://www.fiercepharma.com/pharma/after-rocky-few-months-gileads-trodelvy-keeps-winning-streak-rolling-priority-review
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761149
https://www.reuters.com/business/healthcare-pharmaceuticals/gileads-trodelvy-extends-breast-cancer-survival-by-32-months-study-2022-09-07/
https://www.fiercepharma.com/pharma/needed-boon-gilead-trodelvy-chalks-surprise-breast-cancer-survival-win
https://pharmaphorum.com/news/gilead-sciences-push-into-oncology-is-paying-off-as-veklury-falters/
https://www.fiercepharma.com/marketing/after-historic-win-astrazeneca-and-daiichis-enhertu-could-pressure-gileads-trodelvy
https://www.fiercepharma.com/pharma/asco-gileads-trodelvy-limps-forward-new-breast-cancer-lane-below-par-showing-casts-doubt
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761115
https://www.fiercepharma.com/pharma/gilead-sciences-laying-114-staffers-former-immunomedics-headquarters
https://www.pharmatimes.com/news/smc_approval_welcome_news_for_breast_cancer_patients_1388709
https://www.biospace.com/article/gilead-sciences-says-trodelvy-slows-progression-of-common-form-of-breast-cancer/
https://www.prnewswire.com/news-releases/everest-medicines-announces-first-drug-approval-of-trodelvy-in-singapore-for-second-line-metastatic-triple-negative-breast-cancer-301476174.html
https://eturbonews.com/3013464/new-drug-application-for-metastatic-triple-negative-breast-cancer/
https://www.prnewswire.com/news-releases/everest-medicines-announces-the-acceptance-of-a-new-drug-application-for-sacituzumab-govitecan-in-second-line-metastatic-triple-negative-breast-cancer-in-south-korea-301444148.html
Market Place
Share 
